The findings of this study provide compelling evidence that inhibition of IRAP significantly improves ischemic stroke outcomes and identifies IRAP as a potential target for the development of novel neuroprotective agents for the treatment of ischaemic stroke. This evidence concerns the gene LNPEP and ischemic stroke.